The Direct Thrombin Inhibitor Melagatran and Its Oral Prodrug H 376/95: Intestinal Absorption Properties, Biochemical and Pharmacodynamic Effects
David Gustafsson(AstraZeneca (Sweden)), Jan-Erik Nyström(AstraZeneca (Sweden)), Stefan Carlsson(AstraZeneca (Sweden)), Ulf Bredberg(AstraZeneca (Sweden)), Ulf G. Eriksson(AstraZeneca (Sweden)), Erika Gyzander(AstraZeneca (Sweden)), Margareta Elg(AstraZeneca (Sweden)), Thomas Antonsson(AstraZeneca (Sweden)), Kurt‐Jürgen Hoffmann(AstraZeneca (Sweden)), Anna‐Lena Ungell(AstraZeneca (Sweden)), Henrik Toft Sørensen(AstraZeneca (Sweden)), Sofia Någård(AstraZeneca (Sweden)), Anna Abrahamsson(AstraZeneca (Sweden)), Ruth Bylund(AstraZeneca (Sweden))
Cited by 302
Abstract
Related Papers
No related papers found
Powered by citation graph analysis